Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are tied to a reduction in alcohol intake, according to a researc ...

About 11 million workers who have chronic kidney disease now account for $105 billion in annual employer plan spending.

New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Researchers used data-driven clustering to define 6 distinct obesity subtypes, offering a potential paradigm shift in how ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

Larger bodies gained visibility in recent years. One writer explores the limitations that are now running rampant within the fashion industry regarding plus-size brands and figures.

Eventually, it was proven that Mounjaro is more affective than Wegovy in terms of weight loss, with 32 per cent of ...